Polly A. Murphy - Dec 20, 2021 Form 4 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role: Director
Signature: /s/ Andrea Corcoran, as Attorney-in-Fact for Polly A. Murphy
Stock symbol: AVIR
Transactions as of: Dec 20, 2021
Transactions value $: $102,796
Form type: 4
Date filed: 12/21/2021, 08:41 PM
Previous filing: Jun 21, 2021
Next filing: Jun 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AVIR	Common Stock	Purchase	$103K	+12K	+106.24%	$8.57	23.3K	Dec 20, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.66, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.66, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.